🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Acute Stanford type A aortic dissection (TAAD) is a life-threatening clinic...
Status
Enrolling By Invitation
Location
Francesco Nappi
Start Date
2014-01-01
Trial ID
NCT05912634
Treatments Being Tested
Premature Endothelial Dysfunction is present in patients with early rheumat...
Status
Completed
Location
Orrin M. Troum, MD and Medical Associates
Start Date
2011-12
Trial ID
NCT01499732
This phase II trial examines the use of blood-based biomarkers is to help i...
Status
Recruiting
Location
Mayo Clinic in Arizona
Start Date
2023-02-21
Trial ID
NCT05541016
Treatments Being Tested
We define refractory nasopharyngeal carcinoma as the following: recurrence ...
Status
Unknown
Location
Department of Radiation Oncology, Sun Yat-Sen University Cancer Center
Start Date
2015-07
Trial ID
NCT02590133
Treatments Being Tested
That anti-TNF therapy and rituximab therapy are equally effective in treati...
Status
Completed
Location
NHS Fife
Start Date
2010-04
Trial ID
NCT01021735
Treatments Being Tested
A double-blind, randomized, placebo-controlled, crossover design trial was ...
Status
Terminated
Location
Boston University Psychiatry Research Center, Clinical Studies Unit
Start Date
2019-05-02
Trial ID
NCT03645408
Treatments Being Tested
Background: Neurofibromatosis Type 1 (NF1) is a genetic disorder in which ...
Status
Active Not Recruiting
Location
National Institutes of Health Clinical Center
Start Date
2008-02-25
Trial ID
NCT00924196
Determine whether viagenpumatucel-L combined with low-dose cyclophosphamide...
Status
Terminated
Location
Highlands Oncology Group
Start Date
2014-07
Trial ID
NCT02117024
The purpose of the study is to evaluate the anti-tumor activity of LY252335...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Start Date
2011-08
Trial ID
NCT01416389
Treatments Being Tested
The primary objectives of this study are to evaluate whether Yisui Shengxue...
Status
Completed
Location
Multiple Locations
Start Date
2011-07
Trial ID
NCT01549080
Treatments Being Tested